Following encouraging clinical results, retatrutide, a new peptide option for addressing non-insulin dependent hyperglycemia , has secured regulatory approval from UK’s Drug and Regulatory Agency ( https://shopretatrutidepeptide.com/category/retatrutide-peptide/